title: 7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice.
abstract: We examined the abilities of 7-nitroindazole and methylene blue, inhibitors of the neuronal isoform of nitric oxide synthase (NOS) and nitric oxide-stimulated guanylate cyclase activity respectively, to attenuate explosive episodic jumping behavior(s) ("popping") elicited by MK-801 in mice. MK-801, like phencyclidine (PCP), is a high-affinity, noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor. We have postulated that MK-801-elicited popping behavior in mice represents an animal model of schizophrenia, because popping behavior is markedly inhibited/antagonized by both typical and atypical antipsychotic drugs. In the present study, popping behavior induced by MK-801 was measured using an automated detection system that quantifies vertical displacements on the testing platform. 7-Nitroindazole (100 mg/kg) and methylene blue (32 and 100 mg/kg) significantly reduced the number and force of MK-801-elicited popping behavior. Mouse rotorod performance did not differ between animals receiving 7-nitroindazole, methylene blue, or their respective vehicles, suggesting that attenuation of MK-801-elicited popping behavior was not due to either sedation or ataxia caused by 7-nitroindazole or methylene blue. Our findings suggest that nitric oxide may, in part, mediate behaviors induced by NMDA receptor antagonists, like MK-801, and that inhibitors of NOS may have antipsychotic actions.
authors.affiliation: Department of Veterans Affairs Medical Center, Washington, DC 20422, USA.
authors.forename: S I
authors.initials: SI
authors.lastname: Deutsch
authors.forename: R B
authors.initials: RB
authors.lastname: Rosse
authors.forename: S M
authors.initials: SM
authors.lastname: Paul
authors.forename: V
authors.initials: V
authors.lastname: Tomasino
authors.forename: L
authors.initials: L
authors.lastname: Koetzner
authors.forename: C B
authors.initials: CB
authors.lastname: Morn
authors.forename: J
authors.initials: J
authors.lastname: Mastropaolo
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D016291:Dizocilpine Maleate / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006162:Guanylate Cyclase / Q000187:drug effects; D007191:Indazoles / Q000494:pharmacology*; D008297:Male; D008751:Methylene Blue / Q000494:pharmacology*; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects*
chemical_list: D004791:Enzyme Inhibitors; D007191:Indazoles; D016291:Dizocilpine Maleate; D006162:Guanylate Cyclase; D008751:Methylene Blue; C080122:7-nitroindazole